{"id":236571,"date":"2026-09-16T09:00:00","date_gmt":"2026-09-16T07:00:00","guid":{"rendered":"https:\/\/geneveinfos.ch\/?p=236571"},"modified":"2026-10-08T17:21:28","modified_gmt":"2026-10-08T15:21:28","slug":"apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps","status":"publish","type":"post","link":"https:\/\/geneveinfos.ch\/en\/2026\/09\/16\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\/","title":{"rendered":"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis &#8211; Le Temps"},"content":{"rendered":"<div class=\"wpra-attribution\"><p>Revue de presse via Google News. Pour lire l'article original, cliquez sur le titre ci-dessous (le nom du m\u00e9dia est indiqu\u00e9 apr\u00e8s le titre).<\/p>\n<\/div><p><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMi7gFBVV95cUxNQ2F6YlhKNDExMVpYQWtoRWdCZWRIOHVLVDA0QjBaQ3F4Q3o5T0ZZb1hhMWpTZ0EwcEFDbXQ4SlZwMEM3NFotbkFKcG5QSDR4ak1ueVpWbFFwcXhQOHNGOW5PZHBfMHJ4c1BoZ0ZsNTBCZmtTNTNRWVFMV1lkd1RyYkx1NFZPWlJ6V2ZyRUQ1ZGlTWmxkNzJFd3Q3RjFiWXIwNWpTUzRqUTZ0aVRkbF9LOHN0VXBfS05ERER0amlGTWlYUjdEQU4yTU5GcWFxRmtpYl9uTzA2ZTZ5UDVSNlZSbmctbjJyOEFZX1UzUFZ3?oc=5\" target=\"_blank\">Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis<\/a>\u00a0\u00a0Le Temps<\/p>","protected":false},"excerpt":{"rendered":"<p>Revue de presse via Google News. Pour lire l&rsquo;article original, cliquez sur le titre ci-dessous (le nom du m\u00e9dia est indiqu\u00e9 apr\u00e8s le titre). Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis\u00a0\u00a0Le Temps<\/p>","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[102],"tags":[],"class_list":["post-236571","post","type-post","status-publish","format-standard","hentry","category-pharma-biotech"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.3 - aioseo.com -->\n\t<meta name=\"description\" content=\"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis Le Temps\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"R\u00e9daction Gen\u00e8ve Infos\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/news.google.com\/rss\/articles\/CBMi7gFBVV95cUxNQ2F6YlhKNDExMVpYQWtoRWdCZWRIOHVLVDA0QjBaQ3F4Q3o5T0ZZb1hhMWpTZ0EwcEFDbXQ4SlZwMEM3NFotbkFKcG5QSDR4ak1ueVpWbFFwcXhQOHNGOW5PZHBfMHJ4c1BoZ0ZsNTBCZmtTNTNRWVFMV1lkd1RyYkx1NFZPWlJ6V2ZyRUQ1ZGlTWmxkNzJFd3Q3RjFiWXIwNWpTUzRqUTZ0aVRkbF9LOHN0VXBfS05ERER0amlGTWlYUjdEQU4yTU5GcWFxRmtpYl9uTzA2ZTZ5UDVSNlZSbmctbjJyOEFZX1UzUFZ3?oc=5\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.3\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_GB\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Gen\u00e8ve Infos - Le site d&#039;informations de la r\u00e9gion genevoise\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis \u2013 Le Temps - Gen\u00e8ve Infos\" \/>\n\t\t<meta property=\"og:description\" content=\"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis Le Temps\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/news.google.com\/rss\/articles\/CBMi7gFBVV95cUxNQ2F6YlhKNDExMVpYQWtoRWdCZWRIOHVLVDA0QjBaQ3F4Q3o5T0ZZb1hhMWpTZ0EwcEFDbXQ4SlZwMEM3NFotbkFKcG5QSDR4ak1ueVpWbFFwcXhQOHNGOW5PZHBfMHJ4c1BoZ0ZsNTBCZmtTNTNRWVFMV1lkd1RyYkx1NFZPWlJ6V2ZyRUQ1ZGlTWmxkNzJFd3Q3RjFiWXIwNWpTUzRqUTZ0aVRkbF9LOHN0VXBfS05ERER0amlGTWlYUjdEQU4yTU5GcWFxRmtpYl9uTzA2ZTZ5UDVSNlZSbmctbjJyOEFZX1UzUFZ3?oc=5\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2025\/09\/Capture-decran-2025-09-18-a-16.52.08.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2025\/09\/Capture-decran-2025-09-18-a-16.52.08.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"513\" \/>\n\t\t<meta property=\"og:image:height\" content=\"457\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-09-16T07:00:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-08T15:21:28+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61576016541234\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis \u2013 Le Temps - Gen\u00e8ve Infos\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis Le Temps\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2025\/09\/Capture-decran-2025-09-18-a-16.52.08.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/09\\\/16\\\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\\\/#blogposting\",\"name\":\"Apr\\u00e8s trente ans \\u00e0 Bulle, la pharma belge UCB continue d\\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis \\u2013 Le Temps - Gen\\u00e8ve Infos\",\"headline\":\"Apr\\u00e8s trente ans \\u00e0 Bulle, la pharma belge UCB continue d\\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis &#8211; Le Temps\",\"author\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/wpra-source-author-site-1\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#person\"},\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/09\\\/16\\\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\\\/#articleImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a611ac9406717aef02499144d0e12a8f5e1327b66a2e6023de2c094c4937e1d?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"R\\u00e9daction Gen\\u00e8ve Infos\"},\"datePublished\":\"2026-09-16T09:00:00+02:00\",\"dateModified\":\"2026-10-08T17:21:28+02:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/09\\\/16\\\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/09\\\/16\\\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\\\/#webpage\"},\"articleSection\":\"Pharma &amp; biotech\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/09\\\/16\\\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/#listItem\",\"name\":\"Pharma &amp; biotech\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/#listItem\",\"position\":2,\"name\":\"Pharma &amp; biotech\",\"item\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/09\\\/16\\\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\\\/#listItem\",\"name\":\"Apr\\u00e8s trente ans \\u00e0 Bulle, la pharma belge UCB continue d\\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis &#8211; Le Temps\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/09\\\/16\\\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\\\/#listItem\",\"position\":3,\"name\":\"Apr\\u00e8s trente ans \\u00e0 Bulle, la pharma belge UCB continue d\\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis &#8211; Le Temps\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/#listItem\",\"name\":\"Pharma &amp; biotech\"}}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#person\",\"name\":\"Morgane RAVOUNA\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/09\\\/16\\\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\\\/#personImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bd1e2e1e7cabf66754a14e2181bc3f67cd3c2b9403841e078411545fc405115b?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Morgane RAVOUNA\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/wpra-source-author-site-1\\\/#author\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/wpra-source-author-site-1\\\/\",\"name\":\"R\\u00e9daction Gen\\u00e8ve Infos\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/09\\\/16\\\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a611ac9406717aef02499144d0e12a8f5e1327b66a2e6023de2c094c4937e1d?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"R\\u00e9daction Gen\\u00e8ve Infos\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/09\\\/16\\\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\\\/#webpage\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/09\\\/16\\\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\\\/\",\"name\":\"Apr\\u00e8s trente ans \\u00e0 Bulle, la pharma belge UCB continue d\\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis \\u2013 Le Temps - Gen\\u00e8ve Infos\",\"description\":\"Apr\\u00e8s trente ans \\u00e0 Bulle, la pharma belge UCB continue d\\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis Le Temps\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/09\\\/16\\\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/wpra-source-author-site-1\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/wpra-source-author-site-1\\\/#author\"},\"datePublished\":\"2026-09-16T09:00:00+02:00\",\"dateModified\":\"2026-10-08T17:21:28+02:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/\",\"name\":\"Gen\\u00e8ve Infos\",\"description\":\"Le site d'informations de la r\\u00e9gion genevoise\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#person\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis \u2013 Le Temps - Gen\u00e8ve Infos","description":"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis Le Temps","canonical_url":"https:\/\/news.google.com\/rss\/articles\/CBMi7gFBVV95cUxNQ2F6YlhKNDExMVpYQWtoRWdCZWRIOHVLVDA0QjBaQ3F4Q3o5T0ZZb1hhMWpTZ0EwcEFDbXQ4SlZwMEM3NFotbkFKcG5QSDR4ak1ueVpWbFFwcXhQOHNGOW5PZHBfMHJ4c1BoZ0ZsNTBCZmtTNTNRWVFMV1lkd1RyYkx1NFZPWlJ6V2ZyRUQ1ZGlTWmxkNzJFd3Q3RjFiWXIwNWpTUzRqUTZ0aVRkbF9LOHN0VXBfS05ERER0amlGTWlYUjdEQU4yTU5GcWFxRmtpYl9uTzA2ZTZ5UDVSNlZSbmctbjJyOEFZX1UzUFZ3?oc=5","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/geneveinfos.ch\/en\/2026\/09\/16\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\/#blogposting","name":"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis \u2013 Le Temps - Gen\u00e8ve Infos","headline":"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis &#8211; Le Temps","author":{"@id":"https:\/\/geneveinfos.ch\/en\/author\/wpra-source-author-site-1\/#author"},"publisher":{"@id":"https:\/\/geneveinfos.ch\/en\/#person"},"image":{"@type":"ImageObject","@id":"https:\/\/geneveinfos.ch\/en\/2026\/09\/16\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\/#articleImage","url":"https:\/\/secure.gravatar.com\/avatar\/4a611ac9406717aef02499144d0e12a8f5e1327b66a2e6023de2c094c4937e1d?s=96&d=mm&r=g","width":96,"height":96,"caption":"R\u00e9daction Gen\u00e8ve Infos"},"datePublished":"2026-09-16T09:00:00+02:00","dateModified":"2026-10-08T17:21:28+02:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"https:\/\/geneveinfos.ch\/en\/2026\/09\/16\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\/#webpage"},"isPartOf":{"@id":"https:\/\/geneveinfos.ch\/en\/2026\/09\/16\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\/#webpage"},"articleSection":"Pharma &amp; biotech"},{"@type":"BreadcrumbList","@id":"https:\/\/geneveinfos.ch\/en\/2026\/09\/16\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/geneveinfos.ch\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/#listItem","name":"Pharma &amp; biotech"}},{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/#listItem","position":2,"name":"Pharma &amp; biotech","item":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/","nextItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/2026\/09\/16\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\/#listItem","name":"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis &#8211; Le Temps"},"previousItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/2026\/09\/16\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\/#listItem","position":3,"name":"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis &#8211; Le Temps","previousItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/#listItem","name":"Pharma &amp; biotech"}}]},{"@type":"Person","@id":"https:\/\/geneveinfos.ch\/en\/#person","name":"Morgane RAVOUNA","image":{"@type":"ImageObject","@id":"https:\/\/geneveinfos.ch\/en\/2026\/09\/16\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\/#personImage","url":"https:\/\/secure.gravatar.com\/avatar\/bd1e2e1e7cabf66754a14e2181bc3f67cd3c2b9403841e078411545fc405115b?s=96&d=mm&r=g","width":96,"height":96,"caption":"Morgane RAVOUNA"}},{"@type":"Person","@id":"https:\/\/geneveinfos.ch\/en\/author\/wpra-source-author-site-1\/#author","url":"https:\/\/geneveinfos.ch\/en\/author\/wpra-source-author-site-1\/","name":"R\u00e9daction Gen\u00e8ve Infos","image":{"@type":"ImageObject","@id":"https:\/\/geneveinfos.ch\/en\/2026\/09\/16\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/4a611ac9406717aef02499144d0e12a8f5e1327b66a2e6023de2c094c4937e1d?s=96&d=mm&r=g","width":96,"height":96,"caption":"R\u00e9daction Gen\u00e8ve Infos"}},{"@type":"WebPage","@id":"https:\/\/geneveinfos.ch\/en\/2026\/09\/16\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\/#webpage","url":"https:\/\/geneveinfos.ch\/en\/2026\/09\/16\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\/","name":"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis \u2013 Le Temps - Gen\u00e8ve Infos","description":"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis Le Temps","inLanguage":"en-GB","isPartOf":{"@id":"https:\/\/geneveinfos.ch\/en\/#website"},"breadcrumb":{"@id":"https:\/\/geneveinfos.ch\/en\/2026\/09\/16\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\/#breadcrumblist"},"author":{"@id":"https:\/\/geneveinfos.ch\/en\/author\/wpra-source-author-site-1\/#author"},"creator":{"@id":"https:\/\/geneveinfos.ch\/en\/author\/wpra-source-author-site-1\/#author"},"datePublished":"2026-09-16T09:00:00+02:00","dateModified":"2026-10-08T17:21:28+02:00"},{"@type":"WebSite","@id":"https:\/\/geneveinfos.ch\/en\/#website","url":"https:\/\/geneveinfos.ch\/en\/","name":"Gen\u00e8ve Infos","description":"Le site d'informations de la r\u00e9gion genevoise","inLanguage":"en-GB","publisher":{"@id":"https:\/\/geneveinfos.ch\/en\/#person"}}]},"og:locale":"en_GB","og:site_name":"Gen\u00e8ve Infos - Le site d'informations de la r\u00e9gion genevoise","og:type":"article","og:title":"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis \u2013 Le Temps - Gen\u00e8ve Infos","og:description":"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis Le Temps","og:url":"https:\/\/news.google.com\/rss\/articles\/CBMi7gFBVV95cUxNQ2F6YlhKNDExMVpYQWtoRWdCZWRIOHVLVDA0QjBaQ3F4Q3o5T0ZZb1hhMWpTZ0EwcEFDbXQ4SlZwMEM3NFotbkFKcG5QSDR4ak1ueVpWbFFwcXhQOHNGOW5PZHBfMHJ4c1BoZ0ZsNTBCZmtTNTNRWVFMV1lkd1RyYkx1NFZPWlJ6V2ZyRUQ1ZGlTWmxkNzJFd3Q3RjFiWXIwNWpTUzRqUTZ0aVRkbF9LOHN0VXBfS05ERER0amlGTWlYUjdEQU4yTU5GcWFxRmtpYl9uTzA2ZTZ5UDVSNlZSbmctbjJyOEFZX1UzUFZ3?oc=5","og:image":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2025\/09\/Capture-decran-2025-09-18-a-16.52.08.png","og:image:secure_url":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2025\/09\/Capture-decran-2025-09-18-a-16.52.08.png","og:image:width":513,"og:image:height":457,"article:published_time":"2026-09-16T07:00:00+00:00","article:modified_time":"2026-10-08T15:21:28+00:00","article:publisher":"https:\/\/www.facebook.com\/profile.php?id=61576016541234","twitter:card":"summary_large_image","twitter:title":"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis \u2013 Le Temps - Gen\u00e8ve Infos","twitter:description":"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis Le Temps","twitter:image":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2025\/09\/Capture-decran-2025-09-18-a-16.52.08.png"},"aioseo_meta_data":{"post_id":"236571","title":null,"description":null,"keywords":null,"keyphrases":{"focus":[],"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2026-10-08 12:52:16","updated":"2026-10-08 15:25:36","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/geneveinfos.ch\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/\" title=\"Pharma &amp; biotech\">Pharma &amp; biotech<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tApr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis \u2013 Le Temps\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/geneveinfos.ch\/en\/"},{"label":"Pharma &amp; biotech","link":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/"},{"label":"Apr\u00e8s trente ans \u00e0 Bulle, la pharma belge UCB continue d\u2019investir en Suisse mais se tourne aussi davantage vers les Etats-Unis &#8211; Le Temps","link":"https:\/\/geneveinfos.ch\/en\/2026\/09\/16\/apres-trente-ans-a-bulle-la-pharma-belge-ucb-continue-dinvestir-en-suisse-mais-se-tourne-aussi-davantage-vers-les-etats-unis-le-temps\/"}],"_links":{"self":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts\/236571","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/comments?post=236571"}],"version-history":[{"count":1,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts\/236571\/revisions"}],"predecessor-version":[{"id":236740,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts\/236571\/revisions\/236740"}],"wp:attachment":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/media?parent=236571"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/categories?post=236571"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/tags?post=236571"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}